Cargando…
The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation
BACKGROUND: Angiogenesis, the formation of new blood vessels from existing vasculature, plays an essential role in tumor growth, invasion, and metastasis. 16K hPRL, the antiangiogenic 16-kDa N-terminal fragment of human prolactin was shown to prevent tumor growth and metastasis by modifying tumor ve...
Autores principales: | Nguyen, Ngoc-Quynh-Nhu, Castermans, Karolien, Berndt, Sarah, Herkenne, Stephanie, Tabruyn, Sebastien P., Blacher, Silvia, Lion, Michelle, Noel, Agnes, Martial, Joseph A., Struman, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210157/ https://www.ncbi.nlm.nih.gov/pubmed/22087289 http://dx.doi.org/10.1371/journal.pone.0027318 |
Ejemplares similares
-
Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis
por: Sabatel, Céline, et al.
Publicado: (2010) -
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
por: Sabatel, Céline, et al.
Publicado: (2011) -
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
por: Bovy, Nicolas, et al.
Publicado: (2015) -
Antiangiogenic effects of catalpol on rat corneal neovascularization
por: Han, Yun, et al.
Publicado: (2018) -
Resistance to antiangiogenic therapy is directed by vascular
phenotype, vessel stabilization, and maturation in malignant
melanoma
por: Helfrich, Iris, et al.
Publicado: (2010)